Market Research Logo

Biochips - Global Market Outlook (2015-2022)

Biochips - Global Market Outlook (2015-2022)

According to Stratistics MRC, the Bio Chip Market accounted for $7.35 billion in 2015 and is expected to grow at a CAGR of 19.6% to reach $25.8 billion by 2022. Increasing number of applications in drug discovery euipments, high precision of diagnosis treatments, growing number of cancer treatments leads to the usage of personalized medicine and high advancements in technology are some of the factors driving the market growth. However, unclear guiding principles, lack of awareness of biochips among rural communities and high cost of products are the restraints hampering the market growth during the forecast period. Considerable growth prediction in emerging countries such as China and India act as a opportunity for the biochip market.

DNA biochips segment is expected to witness the highest CAGR across the globe due to its growing applications in biotechnology and drug discovery. North America region is estimated to have largest share across globe, attributed to its factors such as growing aging population and growing incidence of diseases. On the other hand, Asia-Pacific is anticipated to grow at the highest CAGR over the forecast period.

Some of the key players in global Bio Chip market include Abbott Laboratories, Agilent TechnologiesInc., Perkinelmer, Inc., Fluidigm Corporation, Roche Diagnostics, Thermo Fisher Scientific Inc., Cepheid Inc., Bio-Rad Laboratories Inc., GE Healthcare, Illumina Inc., Affymetrix Inc., Beckman Coulter Inc., Life Technologies Corp, Roche, Life Technologies Corp and Biomerieux SA.

Products Covered:
Micro array
Lab-On-A-Chip microarray
Protein Microarray
Other Protein Microarray
DNA Microarray
Other Microarray Types
Tissue Biochips
Carbohydrate Biochips
Microfluidics
Analysis Software
Biochip instruments
Biochip reagents
End Users Covered:
Academic & Research Institute
Biotechnology and Pharmaceutical Companies
Hospitals and Diagnostics Centres
Other End Users


Applications Covered:
Diagnostic Applications
Immune disease diagnostic
Neurological diagnostic
Cardiac diagnostic
Other Applications
Drug Discovery
Structural Biology
Lead Optimization
Preclinical and Clinical Trial
Process R&D
Genomics
Proteomics
Other Applications

Functions Covered:
Micro-RNA
Gene Expression
Epigenetic
Genotyping
Sequence Capture

Regions Covered:
North America
US
Canada
Mexico
Europe
Germany
France
Italy
UK
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia
New Zealand
Rest of Asia Pacific
Rest of the World
Middle East
Brazil
Argentina
South Africa
Egypt

What our report offers:
Market share assessments for the regional and country level segments
Market share analysis of the top industry players
Strategic recommendations for the new entrants
Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements


1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 End User Analysis
3.8 Application Analysis
3.9 Emerging Markets
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global BioChips Market, By Product
5.1 Introduction
5.2 Microarray
5.2.1 Lab-On-A Chip Microarray
5.2.1.1 Drug Discovery
5.2.1.2 Genomics
5.2.1.3 Proteomics
5.2.1.4 Clinical Diagnostics
5.2.1.5 IVD & POC
5.2.1.6 Other Lab-On-A Chip Microarray
5.2.2 Protein Microarray
5.2.2.1 High-Throughput Screening
5.2.2.2 Expression Profiling
5.2.2.3 Drug Discovery
5.2.2.4 Diagnostics
5.2.2.5 Proteomics
5.2.2.6 Other Protein Microarray
5.2.3 DNA Microarray
5.2.3.1 Agricultural Biotechnology
5.2.3.2 Genomics
5.2.3.3 SNP Genotyping
5.2.3.4 Drug Discovery
5.2.3.5 Cancer Diagnosis & Treatment
5.2.3.6 Gene Expression
5.2.3.7 Other DNA Chip Applications
5.2.4 Other Microarray Types
5.2.4.1 Cell Arrays
5.2.4.2 Tissue Arrays
5.2.5 Tissue Biochips
5.2.6 Carbohydrate Biochips
5.3 Microfluidics
5.4 Analysis Software
5.5 Biochip instruments
5.6 Biochip reagents
6 Global BioChips Market, By End User
6.1 Introduction
6.2 Hospitals and Diagnostics Centers
6.3 Biotechnology and Pharmaceutical Companies
6.4 Academic & Research Institutes
6.5 Other End User
7 Global BioChips Market, By Application
7.1 Introduction
7.2 Diagnostic Applications
7.2.1 Immune disease diagnostic
7.2.2 Neurological diagnostic
7.2.3 Cardiac diagnostic
7.2.4 Other Applications
7.3 Drug Discovery
7.3.1 Structural Biology
7.3.2 Lead Optimization
7.3.3 Preclinical and Clinical Trial
7.3.4 Process R&D
7.4 Genomics
7.5 Proteomics
7.6 Other Applications
8 Global BioChips Market, By Function
8.1 Introduction
8.2 Micro-RNA
8.3 Gene Expression
8.4 Epigenetic
8.5 Genotyping
8.6 Sequence Capture
9 Global BioChips Market, By Geography
9.1 North America
9.1.1 US
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 UK
9.2.5 Spain
9.2.6 Rest of Europe
9.3 Asia Pacific
9.3.1 Japan
9.3.2 China
9.3.3 India
9.3.4 Australia
9.3.5 New Zealand
9.3.6 Rest of Asia Pacific
9.4 Rest of the World
9.4.1 Middle East
9.4.2 Brazil
9.4.3 Argentina
9.4.4 South Africa
9.4.5 Egypt
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Abbott Laboratories
11.2 Agilent Technologies, Inc.
11.3 Perkinelmer, Inc.
11.4 Fluidigm Corporation
11.5 Roche Diagnostics
11.6 Thermo Fisher Scientific, Inc.
11.7 Cepheid Inc.
11.8 Bio-Rad Laboratories Inc.
11.9 GE Healthcare
11.10 Illumina, Inc.
11.11 Affymetrix Inc
11.12 Beckman Coulter Inc
11.13 Life Technologies Corp
11.14 Biomerieux SA
List of Tables
Table 1 Global BioChips Market Outlook, By Region (2013-2022) ($MN)
Table 2 Global BioChips Market Outlook, By Product (2013-2022) ($MN)
Table 3 Global BioChips Market Outlook, By Microarray(2013-2022) ($MN)
Table 4 Global BioChips Market Outlook, By Lab-On-A Chip Microarray (2013-2022) ($MN)
Table 5 Global BioChips Market Outlook, By Protein Microarray (2013-2022) ($MN)
Table 6 Global BioChips Market Outlook, By DNA Microarray (2013-2022) ($MN)
Table 7 Global BioChips Market Outlook, By Other Microarray Types (2013-2022) ($MN)
Table 8 Global BioChips Market Outlook, By Tissue Biochips (2013-2022) ($MN)
Table 9 Global BioChips Market Outlook, By Carbohydrate Biochips (2013-2022) ($MN)
Table 10 Global BioChips Market Outlook, By Microfluidics (2013-2022) ($MN)
Table 11 Global BioChips Market Outlook, By Analysis Software (2013-2022) ($MN)
Table 12 Global BioChips Market Outlook, By Biochip instruments (2013-2022) ($MN)
Table 13 Global BioChips Market Outlook, By Biochip reagents (2013-2022) ($MN)
Table 14 Global BioChips Market Outlook, By End User (2013-2022) ($MN)
Table 15 Global BioChips Market Outlook, By Hospitals and Diagnostics Centers (2013-2022) ($MN)
Table 16 Global BioChips Market Outlook, By Biotechnology and Pharmaceutical Companies (2013-2022) ($MN)
Table 17 Global BioChips Market Outlook, By Academic & Research Institutes (2013-2022) ($MN)
Table 18 Global BioChips Market Outlook, By Other End User (2013-2022) ($MN)
Table 19 Global BioChips Market Outlook, By Application (2013-2022) ($MN)
Table 20 Global BioChips Market Outlook, By Diagnostic Applications (2013-2022) ($MN)
Table 21 Global BioChips Market Outlook, By Immune disease diagnostic (2013-2022) ($MN)
Table 22 Global BioChips Market Outlook, By Neurological diagnostic (2013-2022) ($MN)
Table 23 Global BioChips Market Outlook, By Cardiac diagnostic (2013-2022) ($MN)
Table 24 Global BioChips Market Outlook, By Other Applications (2013-2022) ($MN)
Table 25 Global BioChips Market Outlook, By Drug Discovery (2013-2022) ($MN)
Table 26 Global BioChips Market Outlook, By Structural Biology (2013-2022) ($MN)
Table 27 Global BioChips Market Outlook, By Lead Optimization (2013-2022) ($MN)
Table 28 Global BioChips Market Outlook, By Preclinical and Clinical Trial (2013-2022) ($MN)
Table 29 Global BioChips Market Outlook, By Process R&D (2013-2022) ($MN)
Table 30 Global BioChips Market Outlook, By Genomics (2013-2022) ($MN)
Table 31 Global BioChips Market Outlook, By Proteomics (2013-2022) ($MN)
Table 32 Global BioChips Market Outlook, By Other Applications (2013-2022) ($MN)
Table 33 Global BioChips Market Outlook, By Function (2013-2022) ($MN)
Table 34 Global BioChips Market Outlook, By Micro-RNA (2013-2022) ($MN)
Table 35 Global BioChips Market Outlook, By Gene Expression (2013-2022) ($MN)
Table 36 Global BioChips Market Outlook, By Epigenetic (2013-2022) ($MN)
Table 37 Global BioChips Market Outlook, By Genotyping (2013-2022) ($MN)
Table 38 Global BioChips Market Outlook, By Sequence Capture (2013-2022) ($MN)
Table 39 North America BioChips Market Outlook, By Country (2013-2022) ($MN)
Table 40 North America BioChips Market Outlook, By Product (2013-2022) ($MN)
Table 41 North America BioChips Market Outlook, By Microarray(2013-2022) ($MN)
Table 42 North America BioChips Market Outlook, By Lab-On-A Chip Microarray (2013-2022) ($MN)
Table 43 North America BioChips Market Outlook, By Protein Microarray (2013-2022) ($MN)
Table 44 North America BioChips Market Outlook, By DNA Microarray (2013-2022) ($MN)
Table 45 North America BioChips Market Outlook, By Other Microarray Types (2013-2022) ($MN)
Table 46 North America BioChips Market Outlook, By Tissue Biochips (2013-2022) ($MN)
Table 47 North America BioChips Market Outlook, By Carbohydrate Biochips (2013-2022) ($MN)
Table 48 North America BioChips Market Outlook, By Microfluidics (2013-2022) ($MN)
Table 49 North America BioChips Market Outlook, By Analysis Software (2013-2022) ($MN)
Table 50 North America BioChips Market Outlook, By Biochip instruments (2013-2022) ($MN)
Table 51 North America BioChips Market Outlook, By Biochip reagents (2013-2022) ($MN)
Table 52 North America BioChips Market Outlook, By End User (2013-2022) ($MN)
Table 53 North America BioChips Market Outlook, By Hospitals and Diagnostics Centers (2013-2022) ($MN)
Table 54 North America BioChips Market Outlook, By Biotechnology and Pharmaceutical Companies (2013-2022) ($MN)
Table 55 North America BioChips Market Outlook, By Academic & Research Institutes (2013-2022) ($MN)
Table 56 North America BioChips Market Outlook, By Other End User (2013-2022) ($MN)
Table 57 North America BioChips Market Outlook, By Application (2013-2022) ($MN)
Table 58 North America BioChips Market Outlook, By Diagnostic Applications (2013-2022) ($MN)
Table 59 North America BioChips Market Outlook, By Immune disease diagnostic (2013-2022) ($MN)
Table 60 North America BioChips Market Outlook, By Neurological diagnostic (2013-2022) ($MN)
Table 61 North America BioChips Market Outlook, By Cardiac diagnostic (2013-2022) ($MN)
Table 62 North America BioChips Market Outlook, By Other Applications (2013-2022) ($MN)
Table 63 North America BioChips Market Outlook, By Drug Discovery (2013-2022) ($MN)
Table 64 North America BioChips Market Outlook, By Structural Biology (2013-2022) ($MN)
Table 65 North America BioChips Market Outlook, By Lead Optimization (2013-2022) ($MN)
Table 66 North America BioChips Market Outlook, By Preclinical and Clinical Trial (2013-2022) ($MN)
Table 67 North America BioChips Market Outlook, By Process R&D (2013-2022) ($MN)
Table 68 North America BioChips Market Outlook, By Genomics (2013-2022) ($MN)
Table 69 North America BioChips Market Outlook, By Proteomics (2013-2022) ($MN)
Table 70 North America BioChips Market Outlook, By Other Applications (2013-2022) ($MN)
Table 71 North America BioChips Market Outlook, By Function (2013-2022) ($MN)
Table 72 North America BioChips Market Outlook, By Micro-RNA (2013-2022) ($MN)
Table 73 North America BioChips Market Outlook, By Gene Expression (2013-2022) ($MN)
Table 74 North America BioChips Market Outlook, By Epigenetic (2013-2022) ($MN)
Table 75 North America BioChips Market Outlook, By Genotyping (2013-2022) ($MN)
Table 76 North America BioChips Market Outlook, By Sequence Capture (2013-2022) ($MN)
Table 77 Europe BioChips Market Outlook, By Country (2013-2022) ($MN)
Table 78 Europe BioChips Market Outlook, By Product (2013-2022) ($MN)
Table 79 Europe BioChips Market Outlook, By Microarray(2013-2022) ($MN)
Table 80 Europe BioChips Market Outlook, By Lab-On-A Chip Microarray (2013-2022) ($MN)
Table 81 Europe BioChips Market Outlook, By Protein Microarray (2013-2022) ($MN)
Table 82 Europe BioChips Market Outlook, By DNA Microarray (2013-2022) ($MN)
Table 83 Europe BioChips Market Outlook, By Other Microarray Types (2013-2022) ($MN)
Table 84 Europe BioChips Market Outlook, By Tissue Biochips (2013-2022) ($MN)
Table 85 Europe BioChips Market Outlook, By Carbohydrate Biochips (2013-2022) ($MN)
Table 86 Europe BioChips Market Outlook, By Microfluidics (2013-2022) ($MN)
Table 87 Europe BioChips Market Outlook, By Analysis Software (2013-2022) ($MN)
Table 88 Europe BioChips Market Outlook, By Biochip instruments (2013-2022) ($MN)
Table 89 Europe BioChips Market Outlook, By Biochip reagents (2013-2022) ($MN)
Table 90 Europe BioChips Market Outlook, By End User (2013-2022) ($MN)
Table 91 Europe BioChips Market Outlook, By Hospitals and Diagnostics Centers (2013-2022) ($MN)
Table 92 Europe BioChips Market Outlook, By Biotechnology and Pharmaceutical Companies (2013-2022) ($MN)
Table 93 Europe BioChips Market Outlook, By Academic & Research Institutes (2013-2022) ($MN)
Table 94 Europe BioChips Market Outlook, By Other End User (2013-2022) ($MN)
Table 95 Europe BioChips Market Outlook, By Application (2013-2022) ($MN)
Table 96 Europe BioChips Market Outlook, By Diagnostic Applications (2013-2022) ($MN)
Table 97 Europe BioChips Market Outlook, By Immune disease diagnostic (2013-2022) ($MN)
Table 98 Europe BioChips Market Outlook, By Neurological diagnostic (2013-2022) ($MN)
Table 99 Europe BioChips Market Outlook, By Cardiac diagnostic (2013-2022) ($MN)
Table 100 Europe BioChips Market Outlook, By Other Applications (2013-2022) ($MN)
Table 101 Europe BioChips Market Outlook, By Drug Discovery (2013-2022) ($MN)
Table 102 Europe BioChips Market Outlook, By Structural Biology (2013-2022) ($MN)
Table 103 Europe BioChips Market Outlook, By Lead Optimization (2013-2022) ($MN)
Table 104 Europe BioChips Market Outlook, By Preclinical and Clinical Trial (2013-2022) ($MN)
Table 105 Europe BioChips Market Outlook, By Process R&D (2013-2022) ($MN)
Table 106 Europe BioChips Market Outlook, By Genomics (2013-2022) ($MN)
Table 107 Europe BioChips Market Outlook, By Proteomics (2013-2022) ($MN)
Table 108 Europe BioChips Market Outlook, By Other Applications (2013-2022) ($MN)
Table 109 Europe BioChips Market Outlook, By Function (2013-2022) ($MN)
Table 110 Europe BioChips Market Outlook, By Micro-RNA (2013-2022) ($MN)
Table 111 Europe BioChips Market Outlook, By Gene Expression (2013-2022) ($MN)
Table 112 Europe BioChips Market Outlook, By Epigenetic (2013-2022) ($MN)
Table 113 Europe BioChips Market Outlook, By Genotyping (2013-2022) ($MN)
Table 114 Europe BioChips Market Outlook, By Sequence Capture (2013-2022) ($MN)
Table 115 Asia pacific BioChips Market Outlook, By Country (2013-2022) ($MN)
Table 116 Asia pacific BioChips Market Outlook, By Product (2013-2022) ($MN)
Table 117 Asia pacific BioChips Market Outlook, By Microarray(2013-2022) ($MN)
Table 118 Asia pacific BioChips Market Outlook, By Lab-On-A Chip Microarray (2013-2022) ($MN)
Table 119 Asia pacific BioChips Market Outlook, By Protein Microarray (2013-2022) ($MN)
Table 120 Asia pacific BioChips Market Outlook, By DNA Microarray (2013-2022) ($MN)
Table 121 Asia pacific BioChips Market Outlook, By Other Microarray Types (2013-2022) ($MN)
Table 122 Asia pacific BioChips Market Outlook, By Tissue Biochips (2013-2022) ($MN)
Table 123 Asia pacific BioChips Market Outlook, By Carbohydrate Biochips (2013-2022) ($MN)
Table 124 Asia pacific BioChips Market Outlook, By Microfluidics (2013-2022) ($MN)
Table 125 Asia pacific BioChips Market Outlook, By Analysis Software (2013-2022) ($MN)
Table 126 Asia pacific BioChips Market Outlook, By Biochip instruments (2013-2022) ($MN)
Table 127 Asia pacific BioChips Market Outlook, By Biochip reagents (2013-2022) ($MN)
Table 128 Asia pacific BioChips Market Outlook, By End User (2013-2022) ($MN)
Table 129 Asia pacific BioChips Market Outlook, By Hospitals and Diagnostics Centers (2013-2022) ($MN)
Table 130 Asia pacific BioChips Market Outlook, By Biotechnology and Pharmaceutical Companies (2013-2022) ($MN)
Table 131 Asia pacific BioChips Market Outlook, By Academic & Research Institutes (2013-2022) ($MN)
Table 132 Asia pacific BioChips Market Outlook, By Other End User (2013-2022) ($MN)
Table 133 Asia pacific BioChips Market Outlook, By Application (2013-2022) ($MN)
Table 134 Asia pacific BioChips Market Outlook, By Diagnostic Applications (2013-2022) ($MN)
Table 135 Asia pacific BioChips Market Outlook, By Immune disease diagnostic (2013-2022) ($MN)
Table 136 Asia pacific BioChips Market Outlook, By Neurological diagnostic (2013-2022) ($MN)
Table 137 Asia pacific BioChips Market Outlook, By Cardiac diagnostic (2013-2022) ($MN)
Table 138 Asia pacific BioChips Market Outlook, By Other Applications (2013-2022) ($MN)
Table 139 Asia pacific BioChips Market Outlook, By Drug Discovery (2013-2022) ($MN)
Table 140 Asia pacific BioChips Market Outlook, By Structural Biology (2013-2022) ($MN)
Table 141 Asia pacific BioChips Market Outlook, By Lead Optimization (2013-2022) ($MN)
Table 142 Asia pacific BioChips Market Outlook, By Preclinical and Clinical Trial (2013-2022) ($MN)
Table 143 Asia pacific BioChips Market Outlook, By Process R&D (2013-2022) ($MN)
Table 144 Asia pacific BioChips Market Outlook, By Genomics (2013-2022) ($MN)
Table 145 Asia pacific BioChips Market Outlook, By Proteomics (2013-2022) ($MN)
Table 146 Asia pacific BioChips Market Outlook, By Other Applications (2013-2022) ($MN)
Table 147 Asia pacific BioChips Market Outlook, By Function (2013-2022) ($MN)
Table 148 Asia pacific BioChips Market Outlook, By Micro-RNA (2013-2022) ($MN)
Table 149 Asia pacific BioChips Market Outlook, By Gene Expression (2013-2022) ($MN)
Table 150 Asia pacific BioChips Market Outlook, By Epigenetic (2013-2022) ($MN)
Table 151 Asia pacific BioChips Market Outlook, By Genotyping (2013-2022) ($MN)
Table 152 Asia pacific BioChips Market Outlook, By Sequence Capture (2013-2022) ($MN)
Table 153 RoW BioChips Market Outlook, By Country (2013-2022) ($MN)
Table 154 RoW BioChips Market Outlook, By Product (2013-2022) ($MN)
Table 155 RoW BioChips Market Outlook, By Microarray(2013-2022) ($MN)
Table 156 RoW BioChips Market Outlook, By Lab-On-A Chip Microarray (2013-2022) ($MN)
Table 157 RoW BioChips Market Outlook, By Protein Microarray (2013-2022) ($MN)
Table 158 RoW BioChips Market Outlook, By DNA Microarray (2013-2022) ($MN)
Table 159 RoW BioChips Market Outlook, By Other Microarray Types (2013-2022) ($MN)
Table 160 RoW BioChips Market Outlook, By Tissue Biochips (2013-2022) ($MN)
Table 161 RoW BioChips Market Outlook, By Carbohydrate Biochips (2013-2022) ($MN)
Table 162 RoW BioChips Market Outlook, By Microfluidics (2013-2022) ($MN)
Table 163 RoW BioChips Market Outlook, By Analysis Software (2013-2022) ($MN)
Table 164 RoW BioChips Market Outlook, By Biochip instruments (2013-2022) ($MN)
Table 165 RoW BioChips Market Outlook, By Biochip reagents (2013-2022) ($MN)
Table 166 RoW BioChips Market Outlook, By End User (2013-2022) ($MN)
Table 167 RoW BioChips Market Outlook, By Hospitals and Diagnostics Centers (2013-2022) ($MN)
Table 168 RoW BioChips Market Outlook, By Biotechnology and Pharmaceutical Companies (2013-2022) ($MN)
Table 169 RoW BioChips Market Outlook, By Academic & Research Institutes (2013-2022) ($MN)
Table 170 RoW BioChips Market Outlook, By Other End User (2013-2022) ($MN)
Table 171 RoW BioChips Market Outlook, By Application (2013-2022) ($MN)
Table 172 RoW BioChips Market Outlook, By Diagnostic Applications (2013-2022) ($MN)
Table 173 RoW BioChips Market Outlook, By Immune disease diagnostic (2013-2022) ($MN)
Table 174 RoW BioChips Market Outlook, By Neurological diagnostic (2013-2022) ($MN)
Table 175 RoW BioChips Market Outlook, By Cardiac diagnostic (2013-2022) ($MN)
Table 176 RoW BioChips Market Outlook, By Other Applications (2013-2022) ($MN)
Table 177 RoW BioChips Market Outlook, By Drug Discovery (2013-2022) ($MN)
Table 178 RoW BioChips Market Outlook, By Structural Biology (2013-2022) ($MN)
Table 179 RoW BioChips Market Outlook, By Lead Optimization (2013-2022) ($MN)
Table 180 RoW BioChips Market Outlook, By Preclinical and Clinical Trial (2013-2022) ($MN)
Table 181 RoW BioChips Market Outlook, By Process R&D (2013-2022) ($MN)
Table 182 RoW BioChips Market Outlook, By Genomics (2013-2022) ($MN)
Table 183 RoW BioChips Market Outlook, By Proteomics (2013-2022) ($MN)
Table 184 RoW BioChips Market Outlook, By Other Applications (2013-2022) ($MN)
Table 185 RoW BioChips Market Outlook, By Function (2013-2022) ($MN)
Table 186 RoW BioChips Market Outlook, By Micro-RNA (2013-2022) ($MN)
Table 187 RoW BioChips Market Outlook, By Gene Expression (2013-2022) ($MN)
Table 188 RoW BioChips Market Outlook, By Epigenetic (2013-2022) ($MN)
Table 189 RoW BioChips Market Outlook, By Genotyping (2013-2022) ($MN)
Table 190 RoW BioChips Market Outlook, By Sequence Capture (2013-2022) ($MN)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report